Answer
The median half-life of lenacapavir sodium after subcutaneous administration ranges from 8 to 12 weeks.
Sources for this answer
- Sunlenca 464 mg solution for injectionGilead Sciences Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 6Document updated
Sources checked